Owing to their agonist action on dopaminergic systems, cannabinoids may play a major role in substance dependency and schizophrenia. We examined the (AAT)n triplet repeat polymorphism nearby the CNR1 gene, which encodes human cannabinoid (CB1) receptor, in a male Afro-Caribbean population. The allelic and genotypic distributions were significantly different in non-schizophrenic cocaine dependents (n ¼ 97), schizophrenic cocaine dependents (n ¼ 45) and matched controls (n ¼ 88) (Po10
Introduction
Cannabis is the most widely used illicit drug in Western countries. Owing to their role in the regulation of dopamine (DA) release, cannabinoids may play a major role in the susceptibility to other substance dependency such as cocaine, and may also be involved in vulnerability to schizophrenia. The cannabinoid hypothesis for the pathogenesis of schizophrenia was first based on clinical data. Cannabis consumption can precipitate the psychotic state of schizophrenia, and worsen positive symptoms with hallucinations and delusions. It also induces an emotional syndrome with attentional and cognitive impairment that mimics the negative syndromes of schizophrenia. A longitudinal study of Swedish conscripts 1, 2 and other researches point at a possible causal relationship between schizophrenia and the use of cannabis. 3, [4] [5] [6] As the discovery of Gprotein-coupled seven-transmembrane-domain cannabinoid receptor (CB1) 7 and the cloning of the brain cannabinoid receptor gene (CNR1), 8 more is known about the mechanisms of action of delta-9-tetra hydrocannabinol, the main active ingredient of cannabis. Binding studies have shown that CB1 receptors are abundantly expressed in the brain, especially in limbic and cortical areas (striatum, substantia nigra, nucleus accumbens). 9 Intraperitoneal administration of anandamide, the natural ligand of CB1 receptor, in rats causes a significant decrease in tyrosine hydroxylase and a decrease in the ratio of D1 and D2 receptors in the striatum. 10 In reverse, interruption of DA neurotransmission by 6-hydroxydopamine lesions results in a 45% increase in cannabinoid receptor mRNA level in rats caudate. 11 The synthetic cannabinoid agonist, HU210, provokes relapse to cocaine seeking, and the selective CB1 receptor antagonist, SR141716A, attenuates relapse induced by re-exposure to cocaine-associated cues or by cocaine itself in an animal model of addiction.
12 CB1 is located at 6q14-q15, 13 which was included in a schizophrenia susceptibility locus, 6q13-q26.
14 Therefore, the CNR1 gene appears as a candidate in substance dependency and in schizophrenia. We performed an association study of the polymorphic triplet repeat (AAT)n nearby the CNR1 gene in non-schizophrenic and schizophrenic cocaine-dependent patients.
Results
We observed nine alleles in total, consisting of (AAT)9 to (AAT)18 repeats size, with (AAT)10 repeats size absent. The allelic distribution of the (AAT)n triplet repeat of CNR1 (Table 1) was significantly different between the two groups of patients compared to controls (T1 for non-schizophrenic cocaine dependents:
À4
, for schizophrenic cocaine dependents: w 2 ¼ 37.5, Po10 À4 ). The rate of the (AAT)12 repeat allele among the two groups of patients was higher than in controls (CLUMP T3:
) using the allele division p(AAT)12 vs 4(AAT)12. The same results were observed for genotypic distributions with a higher rate of genotype containing the (AAT)12 repeat allele in schizophrenic cocaine dependents and non-schizophrenic cocaine dependents than in controls (Table 1) . When using the genotypic division 4(AAT)12/4(AAT)12, differences remained significant with a long allele rate of 42.2% in schizophrenic cocaine dependents, 55.7% in non-schizophrenic cocaine dependents and 88.6% in controls (w 2 ¼ 35.9, 2 df, Po10 À4 ). No significant difference, in allelic and genotypic distribution, was found between non-schizophrenic cocaine dependents and schizophrenic cocaine dependents. We observed an excess of homozygoty (n ¼ 26) (P ¼ 0.03) among the cocaine dependents, compared to the expected number (n ¼ 17), evaluated according to the panmixic distribution.
Alcohol dependence was not significantly different between both groups of patients, and we found, in the entire group of patients, a majority of alcohol abusers (76.1%) comparing to dependents (2.8%) and non-alcoholics (21.1%). The rate of subjects fulfilling cannabis dependence criteria was significantly higher among the schizophrenic cocaine addicts than among non-schizophrenic cocaine addicts (15.6 vs 2.1%; P ¼ 0.007).
Discussion
We reported a robust association between the triplet repeat (AAT)n polymorphism nearby the CNR1 gene and cocaine addiction. Our result was consistent with the earlier study by Table 1 Frequencies in % of allele and genotype of the (AAT)n CNR1 polymorphism among cocaine dependents and controls Comings et al. 15 in a male non-Hispanic Caucasian population, in which a positive association was found in the subgroup of drug-dependent patients using drugs by intense routes (smoked-cocaine or intravenous opiates) but not in the entire group, which included alcoholic and less severely drug-addicted patients. In contrast to the report by Comings et al. 15 of an increased rate of long allele repeats for drug dependents, we found an increased rate of the short allele (AAT)12 in smoked-cocaine dependents. One other study found a positive association in African-American polysubstance abusers, but the authors did not discuss this result. 16 Three other studies did not confirm the association. The first one 17 was performed with heroin dependents in a male and female Chinese population. Results remained negative when comparisons were performed in the subgroup of intravenous heroin dependents and in subgroups of same gender, but no comparison in individuals of same gender was reported in the subgroup of intravenous heroin dependents, although significant differences in distribution were found between males and females. The second one 18 was performed in substance dependents in an American-Caucasian and African-American population. The sex ratio in the sample was not reported. The results remained negative when the subgroup of patients using smoked-cocaine and/or intravenous opiates was examined separately. In the third study, carried out by the present research team, 6 we found no association with the (AAT)n repeat nearby the CNR1 gene in a French-Caucasian population of male heroine dependents.
Variability of these results could be explained by several confounding factors. Stratification bias could be the first of these factors because of the differences in allelic distribution among various ethnicities as it was recently demonstrated in a study by Zhang et al. 16 In previous studies reviewed in Table 2 , the most common allele types were the (AAT)15 and (AAT)16 in Chinese 17 and Japanese 19 controls, and the (AAT)13, (AAT)15 and (AAT)17 in French-Caucasian controls; 6 between African-American controls 16 and the AfricanCaribbean controls in the present study inconsistent results were found.
A second confounding factor could be linked to a heterogeneous population based on gender, differences of phenotype in dependency (polysubstances, severity of dependency) and use of non-standardized or unstructured clinical interviews to obtain diagnoses. In the present study, as we wanted to avoid these caveats, we included only male subjects using cocaine by an intense route (smoked cocaine) and with a diagnosis assessed by a standardized and structured instrument. The non-specificity of the CNR1 gene polymorphism, which has also been associated with alcohol dependence (unpublished data) and hebephrenic Numbering system used by Comings et al.
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CNR1 gene: association with cocaine addiction N Ballon et al schizophrenia, 19 should also be kept in mind as a possible confounding factor. However, in our sample, the rate of alcohol dependency was low and the schizophrenics presented mostly positive symptoms. Our results could be partially explained because of the particular origin of African-Caribbean in the French West Indies; 90% of the islanders are of West African slave descent who immigrated before 1848, and had no admixture with the original inhabitants (Arawak Indians) who were eradicated before 1680. One study of the HLA allele distribution showed the prominent contribution of African origin in the population of the Caribbean island of Martinique 20 ; the excess of homozygoty observed in our population compared to the expected number could be consistent with this latter data.
As described by Zhang, 18 the CNR1 microsatellite examined in our study is not in the coding region but located 18 kb 3 0 to the exon 4 translational start site. These results suggest that this marker could be associated with a nearby variation of the gene that remains to be found.
Methods

Subjects
In the addiction treatment unit (ATU) of Martinique in the French West Indies, 97 non-schizophrenic cocaine dependents and 45 schizophrenic cocaine dependents were included. All male patients admitted in the ATU and fulfilling the DSM-IV criteria of smoked-cocaine abuse or dependence without opiate dependence or abuse were solicited. The 45 schizophrenic cocaine dependents also fulfilled DSM-IV schizophrenia criteria. Eighty-eight blood platelet donors were consecutively recruited as controls at the blood and transfusion center of Martinique, without lifetime of personal and familial psychiatric disorder, including substance abuse (10 controls were not included according to this criteria). All subjects (patients and controls) were male, African Caribbean, had at least three African-Caribbean grandparents and gave their written informed consent. The local ethics committee approved this study.
Assessments
Both patients and controls were evaluated by a psychiatrist or a psychologist, blind to the genotyping results and trained to the Diagnostic Interview of Genetic Studies (DIGS). 21 Non-schizophrenic cocaine dependents (ages mean7s.d.: 35.876.6 years) and schizophrenic cocaine dependents (33.077.6 years) were significantly younger than controls (39.5710.2 years) (P ¼ 10 À4 ). No significant difference was found between both groups of patients concerning family history of psychiatric disorder (15.5 vs 15.6%).
Genotyping
Genomic DNA was extracted from peripheral leukocytes of venous blood samples, collected in EDTA-containing tubes according to standard procedures. The (AAT)n triplet repeat polymorphism was detected after amplification by PCR with forward primer (5 0 -TAC-ATC-TCC-GTC-TGA-TGT-TCC-3 0 ) labelled with IRD800 -MWG Biotech, Germany -and reverse (5 0 -GCT-GCT-TCT-GTT-AAC-CCT-GC-3 0 ). The PCR reaction was carried out in a 20 ml volume containing approximately 50 ng of genomic DNA and thermostable Taq polymerase (ampliTaq, Perking-Elmer Cetus, Rockville, MD, USA). PCR products were visualized by 8% polyacrylamide gel electrophoresis, using LICOR 4000 L sequencer. Genotyping was carried out blind to the clinical status and was at least duplicated.
Twenty homozygous subjects from Krebs et al. 6 previously genotyped by using the same method were used as standards. We sequenced these samples with another 10 homozygous subjects from the African-Caribbean population to identify the exact number of AAT repeats. Fluorescent sequencing of PCR fragments (forward and reverse for each sample) was carried out using the Big Dye Terminator v3.1 sequencing kit (PE Applied Biosystems, Warrington, UK) on a 3100 Avant instrument. Sequences were analyzed with the Sequencing Analysis v5.1 software.
Statistical analysis
Hardy-Weinberg equilibrium was assessed with GENEPOP program. 22 CLUMP 23 software was used to compare allelic distributions between schizophrenic and non-schizophrenic patients and controls. The significance was assessed using a Monte Carlo approach (number of tables with higher X2 value among 5000 simulations of contingent tables having the same marginal totals than the observed distribution). Three statistics are used T1 (w 2 from original table), T3 (w 2 from comparing each column against the rest), T4 (w 2 from 2 Â 2 table clumped to produce maximum X2). Quantitative clinical variables were compared between the three groups (N ¼ 97, N ¼ 45, N ¼ 98) with ANOVA, or between the two groups of patients with t-test. Within group, comparisons were performed with paired t-test.
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